|
HS Code |
269400 |
| Iupac Name | 2-[(1S,2S)-1-ethyl-2-(phenylmethoxy)propyl]hydrazinecarboxaldehyde |
| Molecular Formula | C13H20N2O2 |
| Molecular Weight | 236.31 g/mol |
| Smiles | CC[C@@H](COC1=CC=CC=C1)[C@@H](N)C=O |
| Inchi | InChI=1S/C13H20N2O2/c1-2-11(13(15)16)12(14)17-10-9-7-5-3-4-6-8-9/h3-8,11-12H,2,10,14H2,1H3,(H,15,16)/t11-,12-/m0/s1 |
As an accredited 2-[(1S,2S)-1-Ethyl-2-(Phenylmethoxy)Propyl]Hydrazinecarboxaldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Amber glass bottle, 10 grams, with tamper-evident seal, labeled with chemical name, hazard warnings, batch number, and storage instructions. |
| Shipping | This chemical, 2-[(1S,2S)-1-Ethyl-2-(Phenylmethoxy)Propyl]Hydrazinecarboxaldehyde, ships in compliance with all relevant safety regulations. It is typically transported in sealed, appropriately labeled containers, with cushioning to prevent breakage. Shipping methods may require temperature control and documentation of hazardous material handling, depending on the quantity and destination requirements. |
| Storage | Store 2-[(1S,2S)-1-Ethyl-2-(phenylmethoxy)propyl]hydrazinecarboxaldehyde in a tightly sealed container, protected from light and moisture, at 2–8 °C (refrigerator). Keep away from strong acids, bases, oxidizing agents, and sources of ignition. Store in a well-ventilated, dry area. Clearly label the container and ensure only trained personnel handle the substance using appropriate personal protective equipment (PPE). |
Applications of 2-[(1S,2S)-1-Ethyl-2-(Phenylmethoxy)Propyl]Hydrazinecarboxaldehyde in Industrial ManufacturingThis advanced hydrazinecarboxaldehyde derivative is widely used in regulated pharmaceutical synthesis, agrochemical intermediates, specialty polymer manufacturing, and advanced organic synthesis for research and commercial production. Below, we present selected application scenarios that reflect the current industrial demand and compliance requirements for this chemical ingredient across critical supply chains. 1. Active Pharmaceutical Ingredient (API) Intermediate SynthesisOur hydrazinecarboxaldehyde derivative serves as a key protected intermediate for certain chiral hydrazine-based active molecules. The compound is used in the controlled condensation and reduction steps for manufacturing specialized antihypertensive agents and CNS-targeted drugs. Downstream pharmaceutical companies value the product’s enantiomeric purity and stability during multi-step organic synthesis performed under cGMP protocols. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
2. Agrochemical Intermediate ManufactureChemical formulators in the crop protection sector deploy this compound as a critical intermediate in the synthesis of hydrazone-based herbicides and fungicides. It is chosen for its reactivity with select aldehydes and ketones, producing high-yield intermediates applied in downstream formulation. Operators emphasize robust documentation for registrations in key agrochemical markets. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
3. Specialty Polymer Chain-TerminatorThis chiral hydrazinecarboxaldehyde derivative functions as a specialty chain-terminator or cross-linker within high-performance polymer manufacturing. Downstream processors apply the compound during polycondensation stages for engineered plastics where precise molecular weight control and functional end-groups are required for advanced material properties. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
4. Advanced Organic Synthesis and Research ChemicalsContract manufacturing organizations (CMOs) and research labs integrate this compound as a protected hydrazine synthon for custom synthesis of complex heterocyclic compounds, ligands, and chiral catalysts. Its use in small- and pilot-scale operations requires documented chain-of-custody and advanced analytical support to ensure suitability for regulatory filings and scale-up. Industry compliance standards
Typical usage ratio
Downstream process integration
Final product types
|
Competitive 2-[(1S,2S)-1-Ethyl-2-(Phenylmethoxy)Propyl]Hydrazinecarboxaldehyde prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Launching a new intermediate into the fine chemical market never feels routine, especially with a molecule like 2-[(1S,2S)-1-Ethyl-2-(Phenylmethoxy)Propyl]Hydrazinecarboxaldehyde. This compound has roots in our development lines for chiral intermediates supporting pharmaceutical and research synthesis. Chemists searching for hand-in-glove selectivity find value in the stereochemistry embedded in this hydrazinecarboxaldehyde’s backbone. Every batch reflects years of quietly tuning process controls, watching chiral resolution in action, and chasing down unwanted isomerization—so an end-user can count on seeing the right configuration, not just close enough.
Through years of customer feedback and our own internal laboratory trials, we’ve landed on a model for this molecule that consistently delivers the (1S,2S) configuration, paired with a phenylmethoxy group at a key reactive position. Purity specification typically exceeds 98%, as confirmed through high-performance liquid chromatography and chiral column validation. Customers in specialty pharma and academic synthesis often report seamless phase transfer and consistent yield performance, particularly during hydrazone condensation steps. Fine details—like retention of the benzyl protection during downstream reactions—mean users can skip repeat purification or excessive process adjustment.
Our plant team never just finishes a batch and sends it off. Each kilo of this hydrazinecarboxaldehyde gets monitored for residual solvents (always below 0.5%) and byproduct levels, including trace aldehyde or hydrazine starting materials. Internal systems trace every step from raw material testing to final packaging, using batch records maintained across several years, not merely for compliance but to guide process tweaks. Equipment cleaning and dedicated glass lines help fend off cross-contamination, especially for customers working under GMP guidance.
Chemically, the presence of the ethyl and phenylmethoxy groups drives application beyond basic hydrazine derivatives. In the field, project managers working on CNS-active compounds or new-generation pharmaceuticals tell us these substituents help adjust both reactivity and physicochemical properties. Certain hydrazone-forming processes struggle with less specialized analogs. Our customers—especially those running scale-ups in pilot plants—cite how the well-defined stereochemistry and purity sharpen both yield and isolation outcomes. When a hydrazone precursor brings in unwanted isomers or even minute degradation products, everything downstream feels the pain. In our plant, we run forced degradation studies monthly, cataloging impurities before they become anyone else’s problem.
The (1S,2S)-configured core changes more than just process chemistry. Working directly with synthetic groups at several multinational research sites, we see firsthand which impurities create headaches at bench or pilot scale. Our process avoids high-shear mixing near the end-point, favoring gentle stirring and temperature control, to preserve chiral integrity. Even at production scale, we use NMR and LC-MS cross-checks, so every output leaves with a solid data trail. The way the phenylmethoxy arm shields certain reactive centers often comes up in customer meetings. In reactions targeting heterocyclic frameworks, this substituent dampens side reactions and improves selectivity for the desired condensation, saving considerable labor in routine purifications.
Feedback loops run both ways here. Internal QC reports flow directly back to our process chemistry labs. Technicians flag changes in melting points or solubility curves, which prompts quick root-cause hunting. On days when solvent purity slips at the raw material supplier, we’ve identified and stopped off-batch material even before it reached secondary packaging. This hands-on mindset means each drum lands in the user’s hands within spec, batch after batch.
This molecule earns its place with more than molecular weight and a chiral label. Traditional hydrazinecarboxaldehydes often lack strong stereocontrol, leading to multi-step troubleshooting in process lines. We learned early that minute drifts in chiral resolution lead to compounding process problems, so our synthetic route uses chiral catalysts sourced with validated provenance, and every incoming reagent gets identity confirmation. We do not blend or dilute product from multiple lots to “average” out purity—each batch tracks back to a single continuous run, ensuring reliable reproducibility.
Pharmaceutical developers and synthetic chemists share a common frustration when a promising intermediate from a third-party arrives with uncertain configuration or mixed isomers. Our direct manufacturing pedigree matters. By controlling the synthesis environment and watching every step, we built a reliability layer both for regulatory documentation and for labs running high-value or tightly-timed projects. This single-source approach reduces variability, especially in compliant fields where each gram counts.
Out in the field, researchers tell us they switched from lower-cost but non-stereospecific alternatives not just for improved yield but for fewer analytical surprises downstream. For customers matching analytical and process data across continents, batch-to-batch consistency makes a difference. Less time spent chasing analytical ghosts means research timelines stay on track.
Chiral hydrazinecarboxaldehyde intermediates play a pivotal role in active pharmaceutical ingredient development, especially as precursors for CNS agents, anti-cancer candidates, and various antifungals. Many of these molecules start with screening at the preclinical level, where small differences in impurity levels affect the biological profile. In our own R&D partnerships, major advances in chiral catalysis have translated into higher selectivity and yield for end-users. One partner doubled their hit rate in heterocycle libraries after moving to our tighter isomeric controls.
Beyond pharma, academic groups lean on this intermediate for mechanistic studies in organic synthesis. We’ve seen practical use in asymmetric synthesis as a chiral auxiliary or template, giving chemists a new tool for building out libraries with sharper selectivity. The molecule’s robustness under a variety of reaction conditions—acidic, basic, or catalytically active—comes back in customer feedback cycles, where real-world stress-testing trumps lab-bench speculation.
Concerns about aldehyde stability surface regularly in discussions with process chemists. Our material ships with a validated shelf-life and careful moisture protection, down to the smallest laboratory pack. During pack-off, our team checks for water ingress, as hydrazone formation can proceed prematurely in the presence of even minor humidity. The packaging solution uses nitrogen blankets and low-permeability liners, extending stability well beyond a typical lab supply. These changes aren’t theoretical; they grew out of direct complaints from early adopters challenged by partial degradation at crucial steps.
On the purity front, we address not only chemical content but also particulate contamination and solvent residues. QC analysts sample every lot post-filtration and review the data in real time, flagging out-of-trend results for immediate investigation. If heavier byproducts or unreacted hydrazine tails show up above actionable levels, our teams halt release and begin troubleshooting, not just for regulatory reasons, but to maintain trust with research programs that cannot afford uncertainty.
Sourcing issues can often disrupt even the best-planned projects. We maintain forward stock of key raw materials from more than one qualified source, and each month brings a replanning cycle based on order flow and supplier reliability ratings. On more than one occasion, a supply chain disruption at a global scale sent demand our way. We pivot supply chain resources quickly, prioritizing core intermediates to keep our customers on schedule. Instead of third-party warehousing, our facilities manage stock directly, without sending product through layers of distribution that add risk and slowdowns.
One repeating theme with our research and scale-up customers centers on open access to documentation. Every shipment includes certificates detailing chiral purity, residual solvents, and full-elemental profiles. Customers stepping into regulatory submission stages benefit from ready-to-use supporting documentation. This level of transparency speeds up tech transfer, especially for multinational partners who must validate suppliers across several continents. For custom projects, our R&D group can provide split-lot samples, run custom specifications, or even adjust the protection strategy, aiding early-stage research where flexibility counts most.
Some customers move beyond catalog orders, requesting off-books technical support. Application scientists from our team join regular calls with their process chemists, visiting plant sites to solve hands-on issues around scale-up, isolation, or final product stability. These conversations often circle back and drive new investment in our own labs, closing the loop between user feedback and product advancement.
Regulatory shifts toward greener and more sustainable practices motivate our team to scrutinize every aspect of our process, from raw material selection to waste management. Where possible, we choose reaction conditions that minimize solvent use and lower waste output. Our waste management team routinely audits effluent treatment setups to ensure compliance and maintain local support for our production footprint.
Trace levels of hazardous impurities cannot be pushed aside. Our analytical staff monitor for regulated compounds in both intermediate streams and the final product, readying full documentation packages for users in regulated fields. By addressing problem areas before customer audits reveal gaps, we’ve built a reputation as a supplier willing to engage detail at every scale.
We see our role go beyond simply shipping drums. For customers confronting program stoppages owing to delayed intermediates or failed syntheses, a phone call to our technical desk can bring practical solutions—direct shipping, split lots, or in-process analytical support. Our development chemists frequently lend a hand in troubleshooting unexpected outcomes or suggesting alternate pathways using this hydrazinecarboxaldehyde as a starting point.
Open-door policies with our largest buyers lead to early access to experimental batches, supporting pilot plant runs and first-in-human campaigns. Our plant’s flexibility means we can produce specialty grades or tailor outputs in response to unexplored synthetic challenges. These co-developed solutions often become standard offerings, closing process gaps and shortening the route from bench to bulk.
Product launches are rarely just milestones for us—they mark new cycles of learning, constant listening, and slow, steady improvement in both process and product reliability. Each time we review customer trial reports, process maps, or deviation investigations, the lessons feed into process tweaks or equipment upgrades. Rather than focusing only on annual volume growth, we care just as much about minimizing deviations, boosting first-pass quality rates, and building trust one run at a time.
The market doesn’t stand still. Regulatory guidance tightens, synthesis approaches shift, and applications multiply. We keep an eye on adaptation—scouting new chiral catalysts, optimizing protection group strategies, or refining packaging when stability signals warrant. Collaborative projects with academic and industrial R&D teams keep pushing both our standards and the molecule’s potential. This guidance from the field shapes everything from raw material screening to analytical method validation, securing the product’s value and relevance for the next wave of chemical innovation.
Years of hands-on experience—tracking process variables, running pilot batches, answering urgent technical calls—have shaped how we deliver 2-[(1S,2S)-1-Ethyl-2-(Phenylmethoxy)Propyl]Hydrazinecarboxaldehyde. This isn’t just chemical manufacturing; it’s a trust-driven partnership with every chemist, project manager, and technical team counting on reliable, specific performance. The compound’s advanced profile, managed by processes rooted in real-world insight and open feedback channels, enables customers to move more quickly and confidently from bench to bulk. We’ll keep putting transparency, hands-on support, and relentless process improvement at the center of every shipment—because the needs of discovery-led teams demand nothing less.